KRISTEN J PRICE

TitleProfessor
InstitutionMD Anderson
DepartmentCritical Care
Address1515 Holcombe Blvd
Houston TX 77030-4009
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Laserna A, Durán-Crane A, López-Olivo MA, Cuenca JA, Fowler C, Díaz DP, Cardenas YR, Urso C, O'Connell K, Fowler C, Price KJ, Sprung CL, Nates JL. Pain management during the withholding and withdrawal of life support in critically ill patients at the end-of-life: a systematic review and meta-analysis. Intensive Care Med. 2020 09; 46(9):1671-1682. PMID: 32833041.
      Citations: 2     Fields:    Translation:Humans
    2. Stepan K, Bashoura L, George M, Griffith W, Meyer M, Nortjé N, Price K, Zhukovsky DS, Rodriguez MA. Building an Infrastructure and Standard Methodology for Actively Engaging Patients in Advance Care Planning. J Oncol Pract. 2019 12; 15(12):e1085-e1091. PMID: 31596647.
      Citations:    Fields:    Translation:Humans
    3. Rathi NK, Haque SA, Morales F, Kaul B, Ramirez R, Ovu S, Feng L, Dong W, Price KJ, Ugarte S, Raimondi N, Quintero A, Cardenas YR, Nates JL. Variability in triage practices for critically ill cancer patients: A randomized controlled trial. J Crit Care. 2019 10; 53:18-24. PMID: 31174172.
      Citations: 2     Fields:    Translation:Humans
    4. Malik IA, Cardenas-Turanzas M, Gaeta S, Borthakur G, Price K, Cortes J, Nates JL. Sepsis and Acute Myeloid Leukemia: A Population-Level Study of Comparative Outcomes of Patients Discharged From Texas Hospitals. Clin Lymphoma Myeloma Leuk. 2017 Dec; 17(12):e27-e32. PMID: 28844403.
      Citations: 2     Fields:    Translation:HumansPHPublic Health
    5. Bayraktar UD, Milton DR, Shpall EJ, Rondon G, Price KJ, Champlin RE, Nates JL. Prognostic Index for Critically Ill Allogeneic Transplantation Patients. Biol Blood Marrow Transplant. 2017 Jun; 23(6):991-996. PMID: 28263919.
      Citations: 2     Fields:    Translation:Humans
    6. Rathi NK, Haque SA, Nates R, Kosturakis A, Wang H, Dong W, Feng L, Erfe RJ, Guajardo C, Withers L, Finch C, Price KJ, Nates JL. Noninvasivepositive pressure ventilation vsinvasive mechanical ventilation as first-line therapy for acute hypoxemic respiratory failure in cancer patients. J Crit Care. 2017 06; 39:56-61. PMID: 28213266.
      Citations: 7     Fields:    Translation:Humans
    7. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 30688716.
      Citations: 18     Fields:    Translation:Humans
    8. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 31517694.
      Citations: 2     Fields:    Translation:Humans
    9. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 28030995.
      Citations:    Fields:    Translation:Humans
    10. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 20507664.
      Citations: 1     Fields:    Translation:Humans
    11. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 11525059.
      Citations: 1     Fields:    Translation:Humans
    12. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 8049810.
      Citations: 13     Fields:    Translation:Humans
    13. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 10071294.
      Citations: 36     Fields:    Translation:HumansCTClinical Trials
    14. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 9731020.
      Citations: 25     Fields:    Translation:Humans
    15. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 12136227.
      Citations: 9     Fields:    Translation:Humans
    16. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 21844494.
      Citations: 11     Fields:    Translation:Humans
    17. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 20711842.
      Citations: 12     Fields:    Translation:Humans
    18. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 25531284.
      Citations: 15     Fields:    Translation:Humans
    19. Nates JL, Wallace SK, Price KJ. The authors reply. Crit Care Med. 2016 12; 44(12):e1254-e1255. PMID: 27858827.
      Citations:    Fields:    
    20. Wallace SK, Rathi NK, Waller DK, Ensor JE, Haque SA, Price KJ, Piller LB, Tilley BC, Nates JL. Two Decades of ICU Utilization and Hospital Outcomes in a Comprehensive Cancer Center. Crit Care Med. 2016 May; 44(5):926-33. PMID: 26765498.
      Citations: 8     Fields:    Translation:Humans
    21. Namiranian K, Rathi NK, Banchs J, Price KJ, Nates JL, Haque SA. Does Thrombolysis Have a Place in the Cardiopulmonary Resuscitation of Patients With Acute Pulmonary Embolism? A Case of Successful Thrombolysis During Pulmonary Embolism Induced Cardiopulmonary Arrest. Crit Care Med. 2016 May; 44(5):e300-3. PMID: 26584192.
      Citations: 3     Fields:    Translation:Humans
    22. Wallace SK, Waller DK, Tilley BC, Piller LB, Price KJ, Rathi N, Haque S, Nates JL. Place of Death among Hospitalized Patients with Cancer at the End of Life. J Palliat Med. 2015 Aug; 18(8):667-76. PMID: 25927588.
      Citations: 4     Fields:    Translation:Humans
    23. Bayraktar UD, Shpall EJ, Liu P, Ciurea SO, Rondon G, de Lima M, Cardenas-Turanzas M, Price KJ, Champlin RE, Nates JL. Hematopoietic cell transplantation-specific comorbidity index predicts inpatient mortality and survival in patients who received allogeneic transplantation admitted to the intensive care unit. J Clin Oncol. 2013 Nov 20; 31(33):4207-14. PMID: 24127454.
      Citations: 20     Fields:    Translation:Humans
    24. Price KJ, Cardenas-Turanzas M, Lin H, Roden L, Nigam R, Nates JL. Prognostic indicators of mortality of mechanically ventilated patients with acute leukemia in a comprehensive cancer center. Minerva Anestesiol. 2013 Feb; 79(2):147-55. PMID: 23032926.
      Citations: 4     Fields:    Translation:Humans
    25. Cárdenas-Turanzas M, Ensor J, Wakefield C, Zhang K, Wallace SK, Price KJ, Nates JL. Cross-validation of a Sequential Organ Failure Assessment score-based model to predict mortality in patients with cancer admitted to the intensive care unit. J Crit Care. 2012 Dec; 27(6):673-80. PMID: 22762932.
      Citations: 10     Fields:    Translation:Humans
    26. Lahoti A, Nates JL, Wakefield CD, Price KJ, Salahudeen AK. Costs and outcomes of acute kidney injury in critically ill patients with cancer. J Support Oncol. 2011 Jul-Aug; 9(4):149-55. PMID: 21809520.
      Citations: 11     Fields:    Translation:Humans
    27. Cardenas-Turanzas M, Gaeta S, Ashoori A, Price KJ, Nates JL. Demographic and clinical determinants of having do not resuscitate orders in the intensive care unit of a comprehensive cancer center. J Palliat Med. 2011 Jan; 14(1):45-50. PMID: 21194303.
      Citations: 8     Fields:    Translation:Humans
    28. Nates JL, Cárdenas-Turanzas M, Ensor J, Wakefield C, Wallace SK, Price KJ. Cross-validation of a modified score to predict mortality in cancer patients admitted to the intensive care unit. J Crit Care. 2011 Aug; 26(4):388-94. PMID: 21195582.
      Citations: 2     Fields:    Translation:Humans
    29. Nates JL, Cárdenas-Turanzas M, Wakefield C, Kish Wallace S, Shaw A, Samuels JA, Ensor J, Price KJ. Automating and simplifying the SOFA score in critically ill patients with cancer. Health Informatics J. 2010 Mar; 16(1):35-47. PMID: 20413411.
      Citations: 9     Fields:    Translation:Humans
    30. Gaeta S, Price KJ. End-of-life issues in critically ill cancer patients. Crit Care Clin. 2010 Jan; 26(1):219-27. PMID: 19944283.
      Citations: 6     Fields:    Translation:Humans
    31. Cesta MA, Cardenas-Turanzas M, Wakefield C, Price KJ, Nates JL. Life-supportive therapy withdrawal and length of stay in a large oncologic intensive care unit at the end of life. J Palliat Med. 2009 Aug; 12(8):713-8. PMID: 19586391.
      Citations: 5     Fields:    Translation:Humans
    32. Salahudeen AK, Kumar V, Madan N, Xiao L, Lahoti A, Samuels J, Nates J, Price K. Sustained low efficiency dialysis in the continuous mode (C-SLED): dialysis efficacy, clinical outcomes, and survival predictors in critically ill cancer patients. Clin J Am Soc Nephrol. 2009 Aug; 4(8):1338-46. PMID: 19628685.
      Citations: 13     Fields:    Translation:Humans
    33. Cardenas-Turanzas M, Cesta MA, Wakefield C, Wallace SK, Puana R, Price KJ, Nates JL. Factors associated with anemia in patients with cancer admitted to an intensive care unit. J Crit Care. 2010 Mar; 25(1):112-9. PMID: 19577413.
      Citations: 1     Fields:    Translation:Humans
    34. Nates JL, Aravindan N, Hirsch-Ginsberg C, Sizer KC, Kee S, Nguyen AT, Chen K, Shaw AD, Price KJ. Critically ill cancer patients are not consistently hypercoagulable after craniotomy. Neurocrit Care. 2007; 7(3):211-6. PMID: 17968522.
      Citations: 4     Fields:    Translation:HumansCTClinical Trials
    35. Aravindan N, Cata JP, Hoffman L, Dougherty PM, Riedel BJ, Price KJ, Shaw AD. Effects of isoflurane, pentobarbital, and urethane on apoptosis and apoptotic signal transduction in rat kidney. Acta Anaesthesiol Scand. 2006 Nov; 50(10):1229-37. PMID: 16978161.
      Citations: 10     Fields:    Translation:AnimalsCells
    36. Hanna HA, Raad II, Hackett B, Wallace SK, Price KJ, Coyle DE, Parmley CL. Antibiotic-impregnated catheters associated with significant decrease in nosocomial and multidrug-resistant bacteremias in critically ill patients. Chest. 2003 Sep; 124(3):1030-8. PMID: 12970034.
      Citations: 10     Fields:    Translation:HumansCells
    37. Groeger JS, Glassman J, Nierman DM, Wallace SK, Price K, Horak D, Landsberg D. Probability of mortality of critically ill cancer patients at 72 h of intensive care unit (ICU) management. Support Care Cancer. 2003 Nov; 11(11):686-95. PMID: 12905057.
      Citations: 8     Fields:    Translation:HumansCTClinical Trials
    38. Kish Wallace S, Martin CG, Shaw AD, Price KJ. Influence of an advance directive on the initiation of life support technology in critically ill cancer patients. Crit Care Med. 2001 Dec; 29(12):2294-8. PMID: 11801828.
      Citations: 16     Fields:    Translation:Humans
    39. Ewer MS, Kish SK, Martin CG, Price KJ, Feeley TW. Characteristics of cardiac arrest in cancer patients as a predictor of survival after cardiopulmonary resuscitation. Cancer. 2001 Oct 01; 92(7):1905-12. PMID: 11745264.
      Citations: 16     Fields:    Translation:Humans
    40. Escalante CP, Martin CG, Elting LS, Price KJ, Manzullo EF, Weiser MA, Harle TS, Cantor SB, Rubenstein EB. Identifying risk factors for imminent death in cancer patients with acute dyspnea. J Pain Symptom Manage. 2000 Nov; 20(5):318-25. PMID: 11068153.
      Citations: 8     Fields:    Translation:Humans
    41. Kish SK, Martin CG, Price KJ. Advance directives in critically ill cancer patients. Crit Care Nurs Clin North Am. 2000 Sep; 12(3):373-83. PMID: 11855241.
      Citations: 8     Fields:    Translation:Humans
    42. Groeger JS, Lemeshow S, Price K, Nierman DM, White P, Klar J, Granovsky S, Horak D, Kish SK. Multicenter outcome study of cancer patients admitted to the intensive care unit: a probability of mortality model. J Clin Oncol. 1998 Feb; 16(2):761-70. PMID: 9469368.
      Citations: 47     Fields:    Translation:Humans
    43. Escalante CP, Martin CG, Elting LS, Cantor SB, Harle TS, Price KJ, Kish SK, Manzullo EF, Rubenstein EB. Dyspnea in cancer patients. Etiology, resource utilization, and survival-implications in a managed care world. Cancer. 1996 Sep 15; 78(6):1314-9. PMID: 8826956.
      Citations: 21     Fields:    Translation:Humans
    44. Williams JM, Price KJ, Hanson PJ. Investigation of the Ca(2+)-dependency of nitric oxide synthase induced in rat colonic mucosa by intravenous lipopolysaccharide. Biochem Soc Trans. 1995 Aug; 23(3):455S. PMID: 8566346.
      Citations:    Fields:    Translation:Animals
    45. Kilbourn RG, Fonseca GA, Griffith OW, Ewer M, Price K, Striegel A, Jones E, Logothetis CJ. NG-methyl-L-arginine, an inhibitor of nitric oxide synthase, reverses interleukin-2-induced hypotension. Crit Care Med. 1995 Jun; 23(6):1018-24. PMID: 7774211.
      Citations: 4     Fields:    Translation:HumansCTClinical Trials
    46. Predictors of readmission to the intensive care unit at a tertiary cancer center. Critical Care Medicine. 27.
    47. A mortality model for critically ill cancer patients. Chest. 110.
    48. The authors reply. Critical Care Medicine. 44:e1254-e1255.
    49. Benefit of critical care in patients with inoperable lung cancer. Chest. 110.
    50. Pulmonary complications of cancer therapy. Anesthesiology Clinics of North America. 16:563-586.
    51. The outcome of cancer patients undergoing cardiopulmonary resuscitation in a tertiary cancer center. Chest. 114.
    52. Outcome of cardiopulmonary resuscitation in cancer patients admitted to an intensive care unit in a tertiary cancer center. Chest. 114.
    53. Low-, medium- and high-dose steroids with or without aminocaproic acid in adult hematopoietic SCT patients with diffuse alveolar hemorrhage. Bone Marrow Transplantation.
    PRICE's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (235)
    Explore
    _
    Co-Authors (32)
    Explore
    _
    Similar People (60)
    Explore
    _
    Same Department Expand Description
    Explore
    _